|
1
|
Gajewski P, Mejza F and
Niżankowska-Mogilnicka E: Rozpoznanie i leczenie astmy u dorosłych.
Podsumowanie wytycznych GINA 2 014. Med Prakt. 9:2014.In
Polish.
|
|
2
|
Fal A: Alergia, Choroby Alergiczne, Astma.
Medycyna Praktyczna; Kraków: 2010, In Polish.
|
|
3
|
Greenfeder S, Umland SP, Cuss FM, Chapman
RW and Egan RW: Th2 cytokines and asthma. The role of interleukin-5
in allergic eosinophilic disease. Respir Res. 2:71–79. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holgate ST: Pathogenesis of asthma. Clin
Exp Allergy. 38:872–897. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Broide DH: Immunologic and inflammatory
mechanisms that drive asthma progression to remodeling. J Allergy
Clin Immunol. 121:560–570. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torrego A, Hew M, Oates T, Sukkar M and
Fan Chung K: Expression and activation of TGF-beta isoforms in
acute allergen-induced remodelling in asthma. Thorax. 62:307–313.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Panek M, Pietras T, Fabijan A, Zioło J,
Wieteska Ł, Małachowska B, Fendler W, Szemraj J and Kuna P: The
NR3C1 glucocorticoid receptor gene polymorphisms may modulate the
TGF-beta mRNA expression in asthma patients. Inflammation.
38:1479–1492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito K, Chung KF and Adcock IM: Update on
glucocorticoid action and resistance. J Allergy Clin Immunol.
117:522–543. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leung DY and Bloom JW: Update on
glucocorticoid action and resistance. J Allergy Clin Immunol.
111:3–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kino T, De Martino MU, Charmandari E,
Mirani M and Chrousos GP: Tissue glucocorticoid
resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol.
85:457–467. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nicolaides NC, Galata Z, Kino T, Chrousos
GP and Charmandari E: The human glucocorticoid receptor: Molecular
basis of biologic function. Steroids. 75:1–12. 2010. View Article : Google Scholar :
|
|
12
|
Hawkins GA, Amelung PJ, Smith RS,
Jongepier H, Howard TD, Koppelman GH, Meyers DA, Bleecker ER and
Postma DS: Identification of polymorphisms in the human
glucocorticoid receptor gene (NR3C1) in a multi-racial asthma case
and control screening panel. DNA Seq. 15:167–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Panek M, Pietras T, Fabijan A, Miłanowski
M, Wieteska L, Górski P, Kuna P and Szemraj J: Effect of
glucocorticoid receptor gene polymorphisms on asthma phenotypes.
Exp Ther Med. 5:572–580. 2013.PubMed/NCBI
|
|
14
|
de Lange P, Koper JW, Huizenga NA,
Brinkmann AO, de Jong FH, Karl M, Chrousos GP and Lamberts SW:
Differential hormone-dependent transcriptional activation and
-repression by naturally occurring human glucocorticoid receptor
variants. Mol Endocrinol. 11:1156–1164. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pietras T, Panek M, Tworek D, Oszajca K,
Wujcik R, Górski P, Kuna P and Szemraj J: The BclI single
nucleotide polymorphism of the human glucocorticoid receptor gene
h-GR/NR3C1 promoter in patients with bronchial asthma: Pilot study.
Mol Biol Rep. 38:3953–3958. 2011. View Article : Google Scholar :
|
|
16
|
Grzanka A and Jarzab J: Nongenomic effects
of glucocorticoids. Pneumonol Alergol Pol. 77:387–393. 2009.In
Polish.
|
|
17
|
Barnes P: Molecular mechanisms of
glucocorticoid action in asthma. Pulm Pharmacol Ther. 10:3–19.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barnes P: Glucocorticosteroids. Asthma:
Basic Mechanisms and Clinical Management. Barnes P, Rodger I and
Thompson N: 3rd Edition. Academic Press; Cambridge, MA: pp.
725–766. 1998, View Article : Google Scholar
|
|
19
|
Newton R, Barnes P and Adcock I:
Transcription Factors. Asthma: Basic Mechanisms and Clinical
Management. Barnes P, Rodger I and Thompson N: 3rd Edition.
Academic Press; Cambridge, MA: pp. 459–474. 1998, View Article : Google Scholar
|
|
20
|
Komai-Koma M, McKay A, Thomson L, McSharry
C, Chalmers GW, Liew FY and Thomson NC: Immuno-regulatory cytokines
in asthma: IL-15 and IL-13 in induced sputum. Clin Exp Allergy.
31:1441–1448. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arai KI, Lee F, Miyajima A, Miyatake S,
Arai N and Yokota T: Cytokines: Coordinators of immune and
inflammatory responses. Annu Rev Biochem. 59:783–836. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bousquet J, Chanez P, Lacoste JY, Barnéon
G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J
and Godard P: Eosinophilic inflammation in asthma. N Engl J Med.
323:1033–1039. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coyle AJ, Ackerman SJ and Irvin CG:
Cationic proteins induce airway hyperresponsiveness dependent on
charge interactions. Am Rev Respir Dis. 147:896–900. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomasiak-Łozowska MM, Bodzenta-Łukaszyk A,
Tomasiak M, Skiepko R and Zietkowski Z: The role of interleukin 13
and interleukin 5 in astma. Postepy Hig Med Dosw (Online).
64:146–155. 2010.
|
|
25
|
Bierbaum S, Nickel R, Zitnik S, Ahlert I,
Lau S, Deichmann KA, Wahn U and Heinzmann A: Confirmation of
association of IL-15 with pediatric asthma and comparison of
different controls. Allergy. 61:576–580. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jachnik M, Szczepankiewicz A and
Bręborowicz A: Influence of IL15 gene polymorphism on the course of
bronchial asthma in children. Alergia Astma Immunologia.
16:200–204. 2011.
|
|
27
|
Letterio JJ and Roberts AB: TGF-beta: A
critical modulator of immune cell function. Clin Immunol
Immunopathol. 84:244–250. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Panek M, Pietras T, Szemraj J, Fabijan A
and Kuna P: Identification and association of TGFβ-1 expression in
patients with asthma in a Polish population-Lodz metropolitan area
study. Int J Biochem Mol Biol. 4:67–74. 2013.
|
|
29
|
Ten Dijke P, GeurtsVanKessel AH, Foulkes
JG and Le Beau MM: Transforming growth factor type beta 3 maps to
human chromosome 14, Region q23–q24. Oncogene. 3:721–724.
1988.PubMed/NCBI
|
|
30
|
Wahl SM: Transforming growth factor-beta:
Innately bipolar. Curr Opin Immunol. 19:55–62. 2007. View Article : Google Scholar
|
|
31
|
Bottoms SE, Howell JE, Reinhardt AK, Evans
IC and McAnulty RJ: Tgf-beta isoform specific regulation of airway
inflammation and remodelling in a murine model of asthma. PLoS One.
5:e96742010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bossé Y, Stankova J and Rola-Pleszczynski
M: Transforming growth factor-beta1 in asthmatic airway smooth
muscle enlargement: Is fibroblast growth factor-2 required? Clin
Exp Allergy. 40:710–724. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie Q, Shen ZJ, Oh J, Chu H and Malter JS:
Transforming growth factor-β1 antagonizes interleukin-5
pro-survival signaling by activating calpain-1 in primary human
eosinophils. J Clin Cell Immunol Suppl. 1:2011.
|
|
34
|
Pardali K and Moustakas A: Actions of
TGF-beta as tumor suppressor and pro-metastatic factor in human
cancer. Biochim Biophys Acta. 1775:21–62. 2007.
|
|
35
|
Shen ZJ, Esnault S, Rosenthal LA, Szakaly
RJ, Sorkness RL, Westmark PR, Sandor M and Malter JS: Pin1
regulates TGF-beta1 production by activated human and murine
eosinophils and contributes to allergic lung fibrosis. J Clin
Invest. 118:479–490. 2008.PubMed/NCBI
|
|
36
|
Kanzaki M, Shibagaki N, Hatsushika K,
Mitsui H, Inozume T, Okamoto A, Dobashi Y, Ogawa H, Shimada S and
Nakao A: Human eosinophils have an intact Smad signaling pathway
leading to a major transforming growth factor-beta target gene
expression. Int Arch Allergy Immunol. 142:309–317. 2007. View Article : Google Scholar
|
|
37
|
Alam R, Forsythe P, Stafford S and Fukuda
Y: Transforming growth factor beta abrogates the effects of
hematopoietins on eosinophils and induces their apoptosis. J Exp
Med. 179:1041–1045. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pazdrak K, Justement L and Alam R:
Mechanism of inhibition of eosinophil activation by transforming
growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1
nuclear factor. J Immunol. 155:4454–4458. 1995.PubMed/NCBI
|
|
39
|
Goplen N, Gorska MM, Stafford SJ, Rozario
S, Guo L, Liang Q and Alam R: A phosphosite screen identifies
autocrine TGF-beta-driven activation of protein kinase R as a
survival-limiting factor for eosinophils. J Immunol. 180:4256–4264.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao J, Li P and Gao S: Effect of
TGF-beta1 on the expression of IL-12, IL-15, IL-18, IL-4 and IL-10
in heart transplantation rejection in rats. J Huazhong Univ Sci
Technolog Med Sci. 27:643–645. 2007. View Article : Google Scholar
|
|
41
|
Godoy P, Weng HL, Bachmann A, Bulanova E,
Bulfone-Paus S and Dooley S: Interleukin-15 expression is induced
by TGF-beta in hepatocytes: A new role for IL-15 in liver disease?
Z Gastroenterol. 46:2432009.
|
|
42
|
Mak JC, Leung HC, Ho SP, Law BK, Ho AS,
Lam WK, Ip MS and Chan-Yeung MM: Analysis of TGF-beta (1) gene
polymorphisms in Hong Kong Chinese patients with asthma. J Allergy
Clin Immunol. 117:92–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Grainger DJ, Heathcote K, Chiano M,
Snieder H, Kemp PR, Metcalfe JC, Carter ND and Spector TD: Genetic
control of the circulating concentration of transforming growth
factor type beta1. Hum Mol Genet. 8:93–97. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hobbs K, Negri J, Klinnert M, Rosenwasser
LJ and Borish L: Interleukin-10 and transforming growth factor-beta
promoter polymorphisms in allergies and asthma. Am J Respir Crit
Care Med. 158:1958–1962. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pulleyn LJ, Newton R, Adcock IM and Barnes
PJ: TGFbeta1 allele association with asthma severity. Hum Genet.
109:623–627. 2001. View Article : Google Scholar
|
|
46
|
Silverman ES, Palmer LJ, Subramaniam V,
Hallock A, Mathew S, Vallone J, Faffe DS, Shikanai T, Raby BA,
Weiss ST and Shore SA: Transforming growth factor-beta1 promoter
polymorphism C-509T is associated with asthma. Am J Respir Crit
Care Med. 169:214–219. 2004. View Article : Google Scholar
|
|
47
|
Nagpal K, Sharma S, B-Rao C, Nahid S,
Niphadkar PV, Sharma SK and Ghosh B: TGFbeta1 haplotypes and asthma
in Indian populations. J Allergy Clin Immunol. 115:527–533. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Buckova D, IzakovicováHollá L, Benes P,
Znojil V and Vácha J: TGF-beta1 gene polymor phisms. Allergy.
56:1236–1237. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Miller MR, Hankinson J, Brusasco V, Burgos
F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP,
Gustafsson P, et al: Standardisation of spirometry. Eur Respir J.
26:319–338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pietras T, Panek M, Kuprys-Lipinska I,
Oszajca K, Wujcik R, Kuna P, Gorski P and Szemraj J: Frequencies of
BclI, E22E, and N363S of h-GR/NR3C1 restriction fragment length
polymorphisms of glucocorticoid receptor gene in Polish adult
population. Med Sci Monit. 16:CR475–CR479. 2010.PubMed/NCBI
|
|
51
|
Panek M, Pietras T, Antczak A, Fabijan A,
Przemęcka M, Górski P, Kuna P and Szemraj J: The N363S and I559N
single nucleotide polymorphisms of the h-GR/NR3C1 gene in patients
with bronchial asthma. Int J Mol Med. 30:142–150. 2012.PubMed/NCBI
|
|
52
|
Panek M, Pietras T, Antczak A, Górski P,
Kuna P and Szemraj J: The role of functional single nucleotide
polymorphisms of the human glucocorticoid receptor gene NR3C1 in
Polish patients with bronchial asthma. Mol Biol Rep. 39:4749–4757.
2012. View Article : Google Scholar :
|
|
53
|
Panek M, Pietras T, Fabijan A, Zioło J,
Wieteska L, Małachowska B, Fendler W, Szemraj J and Kuna P:
Identification and association of the single nucleotide
polymorphisms, C−509T, C+466T and T+869C, of the TGF-β1 gene in
patients with asthma and their influence on the mRNA expression
level of TGF-β1. Int J Mol Med. 34:975–986. 2014.PubMed/NCBI
|
|
54
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Winer J, Jung CK, Shackel I and Williams
PM: Development and validation of real-time quantitative reverse
transcriptase-polymerase chain reaction for monitoring gene
expression in cardiac myocytes in vitro. Anal Biochem. 270:41–49.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
57
|
DeRijk R, Schaaf M and de Kloet E:
Glucocorticoid receptor variants: Clinical implications. J Steroid
Biochem Mol Biol. 81:103–122. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Szabó V, Borgulya G, Filkorn T, Majnik J,
Bányász I and Nagy ZZ: The variant N363S of glucocorticoid receptor
in steroid-induced ocular hypertension in Hungarian patients
treated with photorefractive keratectomy. Mol Vis. 13:659–666.
2007.PubMed/NCBI
|
|
59
|
Majnik J, Patócs A, Balogh K, Tóth M and
Rácz K: A rapid and simple method for detection of Asn363Ser
polymorphism of the human glucocorticoid receptor gene. J Steroid
Biochem Mol Biol. 92:465–468. 2004. View Article : Google Scholar
|
|
60
|
Huizenga NA, Koper JW, De Lange P, Pols
HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH and
Lamberts SW: A polymorphism in the glucocorticoid receptor gene may
be associated with and increased sensitivity to glucocorticoids in
vivo. J Clin Endocrinol Metab. 83:144–151. 1998.PubMed/NCBI
|
